BRCA mutations are inextricably linked with breasts, but they can also lead to cancer in the pancreas, the prostate, and ...

Testing for BRCA mutations linked to breast and ovarian cancers could become easier and more accessible with the help of artificial intelligence, potentially allowing earlier treatment.

Jewish people in England are being invited to take part in a gene testing programme to identify carriers of BRCA mutations that elevate their risk of breast cancer. The NHS Jewish BRCA Testing ...

women are at low risk for developing BRCA-mutation-associated breast or ovarian cancer. Furthermore, they found fair evidence of ethical, legal, and social harms associated with testing and cited ...

Methods We designed a rapid, digital pathway, supported by a genetics specialist hotline, for delivery of germline testing of BRCA1/BRCA2/PALB2 (BRCA-testing), integrated into routine UK NHS breast ...

Screening for pancreatic cancer is recommended for individuals with the above risk factors around 50 years of age or 10 years ...

DNA testing revolutionizes metastatic castration-resistant prostate cancer prognosis, improving patient outcomes with faster ...

7 14–16 Cumulative ovarian cancer risk to age 80 was estimated to be 44% for BRCA1 mutation carriers and 17% for BRCA2 mutations carriers in a study using data from a prospective cohort.1 This ...